Register to leave a comment, or log in if you already have an account
if one cant think for themselves, can’t decipher good from bad advice,…. they should just accept whatever consequences come their way – ie blame yourself first for being stupid then dish out some blame for others
oh yeah? then why did so many of them get it anyways?”
Cuz they were told by their mortgage broker, their bank, and Alan Greenspan that house prices would only go up, so that in 7 yrs when the ARM resets they would just refi it into another mortgage.
DIBS,
I dont like VNDA. I would short it if it went back up to $14-$15. The $450mil additional payment from Novartis is dependent on very steep sales milestones. I am skeptical that they will be able to reach them given the competitive nature of the schizno market. Also, this mgmt is a bad operator and I fear that they will squander the cash away in expensive acquisitions and clinical trials.
I like TRGT much better. They have a depression drug that is way off the chart in terms of efficacy and their safety profile is good as well.
btw, AIG is down 10% in your face. so much for their book value being $39/share.
if one cant think for themselves, can’t decipher good from bad advice,…. they should just accept whatever consequences come their way – ie blame yourself first for being stupid then dish out some blame for others
Hiya! Quiet day here?
Happy-almost-birthday, DIBS!
“>>most people know that ARMs are very risky
oh yeah? then why did so many of them get it anyways?”
Cuz they were told by their mortgage broker, their bank, and Alan Greenspan that house prices would only go up, so that in 7 yrs when the ARM resets they would just refi it into another mortgage.
Nothing goes up forever. Note even gold.
I celebrated last night, CGar. Philly partner taking me out to dinner tonight at our new fancy pants, right wing republican club.
Unlike the OT, it is largely loon-free.
>>VNDA, Pete.
DIBS,
I dont like VNDA. I would short it if it went back up to $14-$15. The $450mil additional payment from Novartis is dependent on very steep sales milestones. I am skeptical that they will be able to reach them given the competitive nature of the schizno market. Also, this mgmt is a bad operator and I fear that they will squander the cash away in expensive acquisitions and clinical trials.
I like TRGT much better. They have a depression drug that is way off the chart in terms of efficacy and their safety profile is good as well.
btw, AIG is down 10% in your face. so much for their book value being $39/share.
76.4% of people confuse proof with statistics.
DAVE!! What are you doing to celebrate your birthday tomorrow??
“A newly discovered version of the Mona Lisa”
Clearly these people have a LOT of time on their hands.
stevie’s a writer. writers & numbers/statistics are like oil & water.
Even when they know them they will misquote them.